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Abstract 
Introduction: Carotid endarterectomy significantly 
reduces the risk of cerebrovascular events in both 
symptomatic and asymptomatic patients with significant 
carotid stenosis.  The recent American Heart 
Association/American College of Cardiology guidelines 
advise that carotid endarterectomy is only beneficial when 
the perioperative stroke or mortality rate is below 6%.  The 
aim of this study was to review the results of carotid 
endarterectomy performed in Malta by one vascular 
surgeon. 
Methods:  All patients undergoing carotid 
endarterectomy between July 2007 and June 2011 were 
included in the study.  Data was entered prospectively into 
a vascular database.  Retrospective review of the case 
notes of all patients undergoing carotid endarterectomy 
was also performed.  Demographics of the patient cohort 
as well as information about perioperative mortality, 
cerebrovascular events, cardiac events as well as any other 
complications were recorded.  Information was also 
collected about any deaths and cerebrovascular events 
during the follow up period. 
Results: 51 patients underwent carotid 
endarterectomy during the study period. 94% were 
symptomatic (65% CVA; 15% TIA; 10% amaurosis 
fugax; 4% TIA and amaurosis) and 6% asymptomatic. 
46% had an internal carotid artery stenosis of 90% or 
more while the rest had a stenosis of 70% or more. 
31% of patients also had significant contralateral 
carotid stenosis or occlusion. There was one 
postoperative mortality (1.9%) and one patient 
sustained a postoperative lacunar stroke (1.9%).  There 
were no cranial nerve injuries and no bleeding 
requiring return to theatre. The combined perioperative 
mortality and stroke rate in this cohort was 3.9%. 
Conclusions: The combined perioperative 
mortality and stroke rate in this sutdy is better than 
that reported in the major randomised controlled trials.  
The perioperative death and stroke rate is well below 
the threshold level advised by the AHA/ACC.   
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Introduction 
Carotid endarterectomy was developed in the 1950s 
but has now become a well established surgical 
procedure which has been shown in several 
randomized controlled trials to be highly beneficial in 
symptomatic patients with a significant carotid 
stenosis (>70%) at preventing strokes (1-3). Carotid 
endarterectomy is less beneficial in symptomatic 
patients with a 50-60% stenosis and not beneficial in 
patients with less than 50% carotid stenosis (1,2). 
More recently carotid endarterectomy has also been 
shown to be effective at reducing the risk of ipsilateral 
and any stroke by approximately 30% over 3 years in 
asymptomatic patients with a significant stenosis 
although the absolute risk reduction is low and 
consequently the number needed to treat higher (4-6). 
Carotid stenting has been compared to carotid 
endarterectomy in a number of trials in the last few 
years (7-10).  Most of the trials showed that the risks 
of perioperative stroke were higher after carotid 
stenting compared to endarterectomy. Despite this the 
American Heart Association and the American 
College of Cardiology issued guidelines on the 
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management of patients with extracranial carotid disease 
wherein they stated that carotid stenting is an alternative to 
carotid endarterctomy if the periprocedural risks are less 
than 6% (11). This has been vehemently opposed by some 
claiming that the current evidence indicates that carotid 
endarterectomy is still the gold standard in the treatment of 
extracranial carotid disease. 
Currently carotid endarterectomy is offered to patients 
with significant carotid stenoses at Mater Dei Hospital.  
The recently published AHA recommendations clearly 
state that the procedure should only be offered if the 
anticipated rate of perioperative stroke or mortality is less 
than 6%(11).   This article reports the results of patients 
undergoing carotid endarterectomy under the care of one 
vascular surgeon (KC) at Mater Dei Hospital and 
compares these with the reported literature.  The aim of 
this study is to ascertain whether the results of carotid 
endarterectomy in this context are acceptable and to ensure 
that the recommendations of the AHA are being met. 
 
 
Methods 
All patients who underwent carotid endarterectomy 
under the care of one vascular surgeon (KC) at Mater Dei 
Hospital between July 2007 and June 2011 were included. 
Data on these patients were collected prospectively and 
entered into a vascular database.  Data collected included 
details on demographics (gender, age), major risk factors 
for arterial disease (smoking, hypertension, 
hyperlipidaemia, diabetes, renal function, ischaemic heart 
disease), indications for surgery, operative details (side, 
use of patch closure, use of intra-operative shunt), post-
operative complications (including mortality, TIA, stroke, 
cranial nerve injury, wound complications, haemorrhage, 
paraesthesia and others)  and follow up. 
Other data collected included previous carotid 
intervention and pre-operative treatment. Details were also 
collected on HDU/ITU admission, days spent in HDU/ITU, 
total duration of hospital stay and discharge destination. 
The case files of all patients were reviewed between 
July and August 2011 to identify major cardiovascular 
events and other complications beyond the perioperative 
period. A proforma was constructed to ensure that data 
collection was as comprehensive as possible. All data was 
coded to allow easier analysis of the information. A 
database was constructed using data from the 
prospectively collected vascular database and information 
collected from retrospective review of the patient case files. 
SPSS version 16.1 was used to analyse the data. 
 
Results  
Between July 2007 and June 2011 fifty one patients 
underwent carotid endarterectomy. 42 patients (82%) were 
male. The median age was 65 years with a range from 40 
to 80 years. The median follow up period was 41 
weeks 4 days with a range of 6 days to 199 weeks 3 
days. 
 
64% of the cohort were current or previous 
smokers. 38% were diabetics. 22% were also known to 
suffer from ischaemic heart disease having undergone 
previous surgery or percutaneous coronary 
intervention. 32% of patients were hypertensive on 
treatment and 36% were hyperlipidaemic. 
The vast majority of patients (81%) were being 
treated preoperatively with both aspirin and statins. 
6% of this cohort (3 patients) did not take either 
antiplatelet or lipid lowering agents. 6 patients (12%) 
were not on a statin. One patient had previously 
undergone a contralateral carotid endarterectomy and 
another had undergone an attempt at ipsilateral carotid 
endarterectomy by another team but the procedure was 
abandoned because of technical issues.  
65% of patients were referred to the vascular 
surgeon after sustaining a stroke,  15% for transient 
ischemic attack, 10 % for amaurosis fugax while 6% 
were asymptomatic (3 patients) while the remaining 
4% had sustained both amaurosis fugax and transient 
ischaemic attacks. 
46% of the patients had a greater than 90% stenosis 
of the internal carotid artery on preoperative 
assessment, while the remaining 54% had a greater 
than 70% stenosis. 31% of patients also had significant 
contralateral internal carotid artery stenosis (>70%) or 
occlusion. 
All procedures were performed under general 
anaesthetic. 55% of procedures were carried out on the 
left side.  55% of patients were shunted 
intraoperatively. A Brenner shunt was used in all cases 
requiring shunting.  Shunting was on a selective 
practice based on stump pressure and contralateral 
carotid disease.  Patients were shunted if the stump 
pressure was less than 40mmHg or if the contralateral 
carotid system was occluded or significantly stenosed 
(>70%).  All carotid endarterectomies were closed 
with a patch (venous or polyurethane). 
87 % of the patients were admitted to intensive 
care/high dependency unit postoperatively. In 13% of 
cases no ITU/HDU bed was available and these 
patients were either transferred directly to the ward 
after a period of monitoring in the theatre recovery 
area (3 patients) or transferred to the coronary care 
unit (4 patients) for overnight monitoring.   
The vast majority (91%) of patients transferred to 
ITU/HDU postoperatively were only kept overnight 
for monitoring.  4 patients required a longer stay in 
ITU/HDU with the longest stay being 3 days (2 
patients).  
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61% of patients were discharged on the 2nd day post op, 
4% were discharged on 1st day post op. The median 
postoperative stay was 2 days with a mean of 4 days and a 
range of 2-9 days.  
 
Perioperative complications 
There was one death (1.96%) in this cohort.  This was a 
sudden death on the 2nd day post op.  The patient had 
recovered well from his surgery and was due to be 
discharged on the following morning. He was found to be 
in asystole by nursing staff at 3 am in the morning.  The 
resuscitation team was called and cardiopulmonary 
resuscitation was attempted without success. A post 
mortem examination was refused by the family and his 
death was attributed to a cardiovascular event.  
One patient sustained a lacunar stroke in the 
postoperative period (1.96%). This was confirmed on MRI.  
No other strokes or TIAs were recorded in this group of 
patients.  The one death and one stroke give a combined 
perioperative stroke and death rate of 3.9%. 
Two patients had minor bleeding episodes from the 
operative site which did not require intervention and which 
settled spontaneously. Other complications included 
urinary retention, hematuria and dysuria,  ST segment 
depression recorded on the electrocardiogram, chest pain 
but with a normal electrocardiogram and cardiac enzymes, 
right neck swelling at the site of incision and a right basal 
pneumonia. One patient also had a severe headache which 
lasted for 2 days which resolved spontaneously. Four 
patients reported minimal paraesthesia either at the angle 
of the jaw, over the mandible or over the face. No cranial 
nerve injuries were recorded. 
 
Longterm complications 
Complaints recorded within 6 months of surgery 
included numbness at incision site, insertion of a 
permanent pacemaker due to the development of  new 
Wenckebach on the background of a left bundle branch 
block and left axis deviation, grade 1 spondylolisthesis and 
lung cancer. One patient reported severe dizziness and 
vomiting between 6 months and 1 year after surgery. One 
patient sustained an ischemic stroke which was confirmed 
on magnetic resonance imaging more than 1 year after 
surgery. This affected the ipsilateral left temporo-parietal 
region. Carotid scanning revealed no evidence of 
restenosis at the site treated. Considerable atherosclerotic 
plaque in the contralateral side was identified but there 
was no significant stenosis. 
One patient passed away during the follow up period. 
Death occurred almost two years after carotid surgery.  He 
presented with a two day history of epigastric pain, nausea 
and coffee ground vomit and subsequently suffered a 
cardiac arrest. Cardiopulmonary resuscitation was started 
immediately and was transferred to intensive care unit. He 
sustained a second cardiac arrest at ITU but 
cardiopulmonary resuscitation was unsuccessful. 
 
 
Discussion  
This study shows that the perioperative risk of 
stroke and death after carotid endarterectomy 
performed by a vascular team at Mater Dei Hospital is 
3.9%.  Only one perioperative death and one 
perioperative stroke was reported in this series.  This 
figure is well below the 6% quoted in the recent 
AHA/ACC recommendations (11). This figure also 
compares very well with the results reported in the 
major randomized controlled trials.  The European 
Carotid Surgery Trial (ECST) reported a perioperative 
stroke and death rate of 7.5% (1) while the NASCET 
Trial reported a 5.8% rate (2). The Veterans Affairs 
trial reported a 6.5% combined perioperative death and 
stroke rate (12). The perioperative death and stroke 
rate after carotid endarterectomy in symptomatic 
patients in more recent trials has been 6.5% in the 
SPACE trial (7), 3.9% in the EVA-3S (8), 3.4% in the 
ICSS (9) and 3.2% in CREST (10). ICSS reported the 
rate of stroke, death or periprocedural MI at120 days 
at 5.2% (9). ICSS also reported a cranial nerve palsy 
rate of 5.5% and a haematoma rate of 6.1%. 
Furthermore the vast majority of the patients 
operated on in this cohort were symptomatic patients 
with only 6% being asymptomatic. This is in contrast 
with some of the major trials which included a 
significant proportion of asymptomatic subjects. It is 
known that the risks of intervention are significantly 
higher in symptomatic patients. Despite the high 
proportion of symptomatic patients in our study the 
complication rate is as low or lower than any of the 
major trials some of which only allowed surgeons with 
a proven track record of low complication rates to 
participate. 
Although the proportion of patients on effective 
secondary risk factor management in our cohort is 
much higher than most of the trials, there was still a 
small proportion of patients who were not on a statin.  
The main reason for this was that statins are not 
provided free of charge to patients with 
cerebrovascular disease on the Maltese national health 
service as the condition is not one of the Schedule V 
list of conditions.  This is unfortunate as the benefits 
and cost effectiveness of9 this group of drugs in the 
context of carotid disease are well recognized. There is 
also clear evidence that use of statins significantly 
reduces the perioperative risks in patients undergoing 
carotid endarterectomy.  One could speculate that if all 
patients were on statins the preoperative complication 
rate could be reduced further.  Indeed the patient who 
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passed away in the postoperative period was not on statins. 
 A small proportion of patients (3 patients) were not on 
antiplatelet treatment. The reasons for this included the 
fact that they were on anticoagulation for other reasons 
(e.g. atrial fibrillation, prosthetic heart valves) or had 
contraindications. 
It is also encouraging to see that there were no patients 
who required return to theatre for bleeding despite the fact 
that all patients who were on antiplatelet treatment 
continued to take their treatment even during the 
perioperative period.  No major wound infections or patch 
infection were recorded.  No cranial nerve injuries were 
seen and apart from minor paraesthesia in a small number 
of patients around the incision site no other complications 
related to the surgery were identified. 
The recent recommendations published by the 
AHA/ACC suggest that noninvasive imaging of the 
extracranial carotid arteries is reasonable at 1 month, 6 
months and yearly after carotid endarterectomy to assess 
patency and to exclude the development of new and 
contralateral lesions as long as the patient remains a 
candidate for intervention.  This is not our current practice 
but the resources required for implementation of this 
recommendation will need to be addressed.  The 
experience from our study however suggests that this is 
not necessary or is unlikely to be cost effective. Indeed the 
AHA/ACC recommendation is only a class IIa 
recommendation based only on level C evidence. In our 
cohort, out of the 51 patients throughout the follow up 
period only one patient sustained a stroke and when 
scanned this was not related to any restenosis at the site of 
endarterectomy.  In contrast there were 6.8% of patients in 
the ECST trial with a symptomatic stenosis over 70% who 
sustained stroke or surgical death in the follow up period 
after endarterectomy and 9% of symptomatic patients with 
a more than 70% stenosis in the NASCET trial who 
sustained an ipsilateral stroke after endarterectomy. 
The good results obtained in our cohort of patients are 
reassuring but are only possible through the effective and 
committed teamwork involving surgical, neurological, 
medical,  anaesthetic and nursing personnel both in the 
peri- and postoperative periods.  This is the first reported 
series of carotid endarterectomy in Malta and will 
hopefully serve to encourage neurologists, physicians and 
opthalmologists to continue to refer deserving patients 
for this intervention.   
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